Want to see KR:003520 full AI Analyst Report?
YUNGJIN PHARM. CO. LTD (003520) Income Statement
YUNGJIN PHARM. CO. LTD Income Statement
Last quarter (Q2 2026), YUNGJIN PHARM. CO. LTD's total revenue was $61.58B, a decrease of 1.50% from the same quarter last year. In Q2, YUNGJIN PHARM. CO. LTD's net income was $-2.43B. See YUNGJIN PHARM. CO. LTD’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 254.26B | $ 252.04B | $ 234.90B | $ 218.38B | $ 196.07B | |
| $ 75.86B | $ 80.35B | $ 72.59B | $ 64.73B | $ 57.94B | |
| $ 72.45B | $ 71.63B | $ 69.47B | $ 72.10B | $ 71.81B | |
| Depreciation and Amortization | $ 8.79B | $ 8.71B | $ 8.69B | $ 7.78B | $ 7.38B |
| $ 12.20B | $ 16.87B | $ 7.65B | $ -14.30B | $ -6.56B | |
| $ 3.42B | $ 8.72B | $ 3.12B | $ -7.36B | $ -13.88B | |
| $ -3.63B | $ -5.84B | $ -7.04B | $ -15.45B | $ -266.11M | |
| $ -212.00M | $ 2.89B | $ -3.92B | $ -22.81B | $ -14.14B | |
| $ -227.66M | $ 1.23B | $ -3.88B | $ -21.96B | $ -11.58B | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.24 | $ 6.74 | $ -21.19 | $ -120.08 | $ -63.33 |
| Diluted EPS | $ -1.24 | $ 6.74 | $ -21.19 | $ -120.08 | $ -63.33 |
| Weighted Average Shares Outstanding | 194.52M | 182.89M | 182.89M | 182.89M | 182.89M |
| Weighted Average Shares Outstanding (Diluted) | 194.52M | 182.89M | 182.89M | 182.89M | 182.89M |
Currency in KRW